Prostate Cancer - Results from #21140

Controversial predictors of biochemical recurrence after radical prostatectomy: A study from a Latin American (Brazilian) Institution - Abstract March 4, 2014

Serum levels of sex hormone binding globulin (shbg) are not predictive of prostate cancer diagnosis and aggressiveness: results from an italian biopsy cohort - Abstract March 4, 2014

Is robot-assisted radical prostatectomy safe in men with high-risk prostate cancer? Assessment of perioperative outcomes, positive surgical margins, and use of additional cancer treatments - Abstract March 4, 2014

Type and dose of radiotherapy used for initial treatment of non-metastatic prostate cancer - Abstract March 4, 2014

Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: A systematic review - Abstract March 4, 2014

Dyadic effects of coping strategies on emotional state and quality of life in prostate cancer patients and their spouses - Abstract March 4, 2014

Current state of castration-resistant prostate cancer - Abstract March 4, 2014

Managed care implications in castration-resistant prostate cancer - Abstract March 4, 2014

Neoadjuvant therapy for localized prostate cancer: Examining mechanism of action and efficacy within the tumor - Abstract March 4, 2014

Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer - Abstract March 3, 2014

Myriad publishes clinical utility study for Prolaris® March 3, 2014

Radiation therapy in locally advanced and/or relapsed urological tumors - Abstract March 3, 2014

The influence of prior abiraterone treatment on the clinical activity of docetaxel in men with metastatic castration-resistant prostate cancer - Abstract March 3, 2014

Management of enzalutamide, a new hormonal therapy - Abstract March 3, 2014

Pharmacological treatment of patients with advanced prostate cancer - Abstract March 3, 2014

Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy - Abstract March 1, 2014

Targeting metastatic castration-resistant prostate cancer: Mechanisms of progression and novel early therapeutic approaches - Abstract March 1, 2014

Comparison of the morbidity between limited and extended pelvic lymphadenectomy during laparoscopic radical prostatectomy - Abstract March 1, 2014

Stratification of high-risk prostate cancer into prognostic categories: A European multi-institutional study - Abstract March 1, 2014

Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) prognostic tool for prediction of metastases and prostate cancer-specific mortality in patients treated with external beam radiation therapy - Abstract March 1, 2014

Page 1058 of 1437